Gentian Diagnostics ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	172.52	152.07	135.15	101.64	83.12	63.33
Other Revenue	-	-	-	10.29	16.89	15.55
Revenue	172.52	152.07	135.15	111.92	100.01	78.88
Revenue Growth (YoY)	17.42%	12.52%	20.76%	11.91%	26.78%	42.43%
Cost of Revenue	77.53	69.25	70.91	52.64	43.18	32.59
Gross Profit	94.99	82.82	64.25	59.29	56.83	46.3
Selling, General & Admin	53.36	49.78	48.12	37.42	34.35	31.32
Research & Development	23.11	21.92	36.08	-	-	-
Other Operating Expenses	-4.67	-4.6	-7.19	34.86	37.98	26.17
Operating Expenses	71.8	67.09	77.01	82.52	79.68	64.12
Operating Income	23.19	15.72	-12.76	-23.23	-22.85	-17.82
Interest Expense	-3.07	-0.66	-0.8	-1.26	-1.38	-
Interest & Investment Income	2.24	3.59	2.67	1.11	0.09	0.6
Currency Exchange Gain (Loss)	1.5	1.5	0.6	-0.2	-0.6	0.29
Other Non Operating Income (Expenses)	-0.08	-0.08	-0.08	-0.05	-0.06	-0.54
EBT Excluding Unusual Items	23.78	20.06	-10.37	-23.62	-24.79	-17.47
Pretax Income	23.78	20.06	-10.37	-23.62	-24.79	-17.47
Income Tax Expense	-19	-25.23	0.28	-	-	-
Net Income	42.78	45.29	-10.65	-23.62	-24.79	-17.47
Net Income to Common	42.78	45.29	-10.65	-23.62	-24.79	-17.47
Shares Outstanding (Basic)	15	15	15	15	15	15
Shares Outstanding (Diluted)	16	16	15	15	15	15
Shares Change (YoY)	-1.29%	2.21%	-	0.04%	0.07%	0.01%
EPS (Basic)	2.77	2.94	-0.69	-1.53	-1.61	-1.13
EPS (Diluted)	2.75	2.87	-0.69	-1.53	-1.61	-1.13
Free Cash Flow	11.73	12.08	14.5	-22.59	-28.08	-15.24
Free Cash Flow Per Share	0.76	0.77	0.94	-1.47	-1.82	-0.99
Dividend Per Share	0.400	0.400	-	-	-	-
Gross Margin	55.06%	54.46%	47.54%	52.97%	56.83%	58.69%
Operating Margin	13.44%	10.34%	-9.44%	-20.76%	-22.84%	-22.60%
Profit Margin	24.80%	29.79%	-7.88%	-21.10%	-24.79%	-22.15%
Free Cash Flow Margin	6.80%	7.94%	10.73%	-20.18%	-28.07%	-19.32%
EBITDA	26.14	18.6	-9.9	-20.49	-21.32	-16.11
EBITDA Margin	15.15%	12.23%	-7.32%	-18.30%	-21.32%	-20.42%
D&A For EBITDA	2.95	2.88	2.87	2.75	1.53	1.71
EBIT	23.19	15.72	-12.76	-23.23	-22.85	-17.82
EBIT Margin	13.44%	10.34%	-9.44%	-20.76%	-22.84%	-22.60%
Revenue as Reported	-	-	-	111.92	100.01	78.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.